| A Study Comparing Infusion Rates of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis (NCT00887341) | Hoffmann-La Roche | 2009-05-01 |
| Comparison of the Tuberculin Skin Test (TST) and QuantiFERON ®-TB Gold Test (QFT-G) In Patients With Rheumatoid Arthritis Being Considered for Anti-TNF-Alpha Therapy (NCT00925249) | Walter Reed Army Medical Center | 2009-05-01 |
| A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs) (NCT00891020) | Hoffmann-La Roche | 2009-05-01 |
| A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis Patients (NCT00920608) | AstraZeneca | 2009-05-01 |
| A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis (NCT00888745) | Genentech, Inc. | 2009-05-01 |
| Golimumab Safety and Surveillance Program Using the Ingenix NHI Database (NCT01081717) | Janssen Biotech, Inc. | 2009-04-14 |
| Investigating the Impact of Mode of Administration on Item Response (NCT00783991) | Stony Brook University | 2009-04-01 |
| Inflammation and Insulin Resistance in Rheumatoid Arthritis (NCT00763139) | Vanderbilt University | 2009-04-01 |
| Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate (NCT00928317) | Arana Therapeutics Ltd | 2009-04-01 |
| Role of Greyscale and Power Doppler Sonography in Therapy Monitoring in Early Rheumatoid Arthritis (RA) (NCT00854243) | Cairo University | 2009-04-01 |
| A Study to Investigate the Potential for AZD5672 to Affect the Electrical Conduction Pathways in the Heart (NCT00887770) | AstraZeneca | 2009-04-01 |
| Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99 (NCT00931086) | Human Genome Sciences Inc., a GSK Company | 2009-04-01 |
| A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab (NCT00808210) | Genentech, Inc. | 2009-03-05 |
| A Study of Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate Treatment (NCT00810199) | Hoffmann-La Roche | 2009-03-01 |
| Patient Rheumatoid Arthritis Social Support Study (NCT01525654) | Brigham and Women's Hospital | 2009-03-01 |
| Assessment of Wrist Joint and Knee Joint Inflammation in Patients With Rheumatoid Arthritis by Quantitative Three Dimensional Power Doppler Ultrasonography (NCT00858169) | Taichung Veterans General Hospital | 2009-03-01 |
| A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis (NCT00870467) | Abbott | 2009-03-01 |
| Long-term Treatment Study of Certolizumab Pegol Without Coadministration of Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients (NCT00850343) | Astellas Pharma Inc | 2009-03-01 |
| Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients (NCT00851318) | Astellas Pharma Inc | 2009-03-01 |
| AZD5672 Bioavailability Study in Healthy Male and Female Subjects (NCT00871767) | AstraZeneca | 2009-03-01 |
| A Study of Combination Treatment With MabThera (Rituximab) and RoActemra (Tocilizumab) Versus RoActemra in Patients With Rheumatoid Arthritis With an Incomplete Response to Methotrexate (NCT00845832) | Hoffmann-La Roche | 2009-03-01 |
| Observational Safety Study of Rituximab in Patients Diagnosed With Rheumatoid Arthritis (RA) Who Did Not Respond Adequately to TNF-alpha Blocker (NCT02322801) | Hoffmann-La Roche | 2009-03-01 |
| An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) Therapy (NCT00883753) | Hoffmann-La Roche | 2009-03-01 |
| Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis (NCT02721004) | Hoffmann-La Roche | 2009-03-01 |
| Study Evaluating Impact of the Use of a Computer-based Tool on the Clinical Management of RA Patients (NCT00895050) | Pfizer | 2009-03-01 |
| Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid Arthritis (NCT01078155) | AbbVie (prior sponsor, Abbott) | 2009-03-01 |
| Anti-TNF Agents for the Treatment of Rheumatoid Arthritis (NCT00837434) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-03-01 |
| Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis (NCT00847886) | Lexicon Pharmaceuticals | 2009-02-01 |
| Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis. (NCT01172639) | P. Verschueren | 2009-02-01 |
| An Open Label Extension Study in Participants With Rheumatoid Arthritis (NCT00837811) | Eli Lilly and Company | 2009-02-01 |
| Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate (NCT00854685) | Arana Therapeutics Ltd | 2009-02-01 |
| A Study to Assess the Effect of Tocilizumab Plus Methotrexate on Safety and Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis (NCT00754572) | Hoffmann-La Roche | 2009-02-01 |
| Post-Market Study of the 3DKnee™ System (NCT00819481) | Encore Medical, L.P. | 2009-02-01 |
| Effectiveness of Water Exercises on Isokinetic Muscle Strength (NCT01447264) | Federal University of São Paulo | 2009-02-01 |
| BTT-1023 in Rheumatoid Arthritis (NCT00851240) | Biotie Therapies Corp. | 2009-02-01 |
| Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid Arthritis (NCT00777816) | XOMA (US) LLC | 2009-02-01 |
| Safety and Effect on Quality of Life/Work Productivity of Humira in Patients With Rheumatoid Arthritis (NCT01076205) | AbbVie (prior sponsor, Abbott) | 2009-01-12 |
| Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study (NCT00843778) | UCB Pharma | 2009-01-01 |
| Computer Navigation vs Conventional Technique in Knee Arthroplasty (NCT00782444) | Haukeland University Hospital | 2009-01-01 |
| RETRO (REduction of Therapy in RA Patients in Ongoing Remission) (NCT02779114) | University of Erlangen-Nürnberg Medical School | 2009-01-01 |
| Rheumatoid Arthritis Disease Activity Monitor (NCT00989677) | Maxima Medical Center | 2009-01-01 |
| Italian Registry of Arthritis on Biologic Therapy (NCT01543594) | Gruppo Italiano Studio Early Arthritis | 2009-01-01 |
| Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica (NCT00847236) | Lahey Clinic | 2009-01-01 |
| Treatment of Vitamin D Deficiency in Patients With Rheumatoid Arthritis (NCT01426347) | Johns Hopkins University | 2009-01-01 |
| Use of Tocilizumab for Rheumatoid Arthritis (RA) in Daily Routine (NCT02809833) | Hoffmann-La Roche | 2009-01-01 |
| A Study in Normal Healthy People, Testing Different Versions of a Pill That Will be Used to Treat Rheumatoid Arthritis. (NCT00838058) | Pfizer | 2009-01-01 |
| Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RA (NCT00858780) | Pfizer | 2009-01-01 |
| Ascension PyroCarbon Radial Head Study (NCT02405234) | Smith & Nephew, Inc. | 2009-01-01 |
| A Study to Assess the Effect of Tocilizumab on Signs and Symptoms in Patients With Rheumatoid Arthritis (NCT00848120) | Hoffmann-La Roche | 2008-12-31 |
| A Multiple-dose Study of the Safety and Tolerability of REGN88(SAR153191) in Rheumatoid Arthritis Subjects (NCT01011959) | Regeneron Pharmaceuticals | 2008-12-01 |
| A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography (NCT00767325) | Bristol-Myers Squibb | 2008-12-01 |
| n-3 and n-6 Fatty Acids in Rheumatoid Arthritis (NCT01179971) | Charite University, Berlin, Germany | 2008-12-01 |
| Marine Oils and Arthritis (NCT00805116) | National Institute of Nutrition and Seafood Research, Norway | 2008-12-01 |
| Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid Arthritis (NCT00810836) | Biogen | 2008-12-01 |
| Registry of Etanercept Use in Patients With Rheumatoid Arthritis in Clinical Practice in Taiwan (NCT00888576) | Pfizer | 2008-12-01 |
| Safety and Tolerability of Anti-IL-20 in Healthy Volunteers and Patients With Rheumatoid Arthritis (NCT00818064) | Novo Nordisk A/S | 2008-12-01 |
| A Study of Tocilizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic DMARDs (NCT00810277) | Hoffmann-La Roche | 2008-11-30 |
| Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA) (NCT00791921) | Otsuka Pharmaceutical Co., Ltd. | 2008-11-01 |
| Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia (NCT00751387) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-11-01 |
| Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA) (NCT00796705) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-11-01 |
| A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood (NCT00781469) | Imperial College London | 2008-11-01 |
| Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA) (NCT00791999) | Otsuka Pharmaceutical Co., Ltd. | 2008-11-01 |
| A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid Arthritis (NCT00783536) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-11-01 |
| Sleep and Immunity in Rheumatoid Arthritis : Remicade Substudy (NCT00948610) | University of California, Los Angeles | 2008-11-01 |
| The Chinese University of Hong Kong Early Arthritis Study (NCT00901550) | Chinese University of Hong Kong | 2008-11-01 |
| A Study of Tocilizumab in Combination With DMARD Therapy in Patients With Active Rheumatoid Arthritis. (NCT00773461) | Hoffmann-La Roche | 2008-10-31 |
| Study to Evaluate the Safety, PK, PD and Efficacy of AMG 827 in Adults With Rheumatoid Arthritis (NCT00771030) | Amgen | 2008-10-27 |
| A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy (NCT00785928) | Eli Lilly and Company | 2008-10-01 |
| A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis (NCT00779220) | Chugai Pharmaceutical | 2008-10-01 |
| Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients (NCT00768053) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-10-01 |
| BIIB023 (Anti-TWEAK) in Subjects With Rheumatoid Arthritis (NCT00771329) | Biogen | 2008-10-01 |
| A Single Dose Study of the CAM-3001 in Patients With Rheumatoid Arthritis (NCT00771420) | MedImmune Ltd | 2008-10-01 |
| A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521) (NCT00724672) | Merck Sharp & Dohme LLC | 2008-09-01 |
| Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA) (NCT00753454) | UCB Pharma | 2008-09-01 |
| An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy. (NCT00750880) | Hoffmann-La Roche | 2008-09-01 |
| Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs (NCT01083693) | Abbott | 2008-09-01 |
| Atherosclerosis in Rheumatoid Arthritis and Lupus: Restoring Cholesterol Balance (NCT01180361) | NYU Langone Health | 2008-09-01 |
| Bone Resorption, Osteoclastogenesis and Adalimumab (NCT00814866) | Université de Sherbrooke | 2008-09-01 |
| A Study of the Effects of Oral Prednisone in Patients With Rheumatoid Arthritis (MK0000-088) (NCT00746512) | Merck Sharp & Dohme LLC | 2008-09-01 |
| Ultrasonography as a Biomarker in Early Rheumatoid Arthritis (NCT00781989) | Imperial College London | 2008-09-01 |
| A Safety and Tolerability Study of REGN88(SAR153191) in Subjects With Rheumatoid Arthritis (NCT01026519) | Regeneron Pharmaceuticals | 2008-09-01 |
| Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA) (NCT00717808) | Imperial College London | 2008-09-01 |
| Spacing of TNF-blocker Injections in Rheumatoid Arthritis Study (NCT00780793) | Assistance Publique - Hôpitaux de Paris | 2008-09-01 |
| Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects (NCT00706797) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-09-01 |
| Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan (NCT00747578) | Taichung Veterans General Hospital | 2008-09-01 |
| Living Well With Rheumatoid Arthritis (NCT00869349) | Brigham and Women's Hospital | 2008-09-01 |
| A Study to Assess Efficacy With Respect to Clinical Improvement in Disease Activity and Safety of Tocilizumab in Patients Wtih Active Rheumatoid Arthritis. (NCT00754559) | Hoffmann-La Roche | 2008-08-01 |
| Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies (NCT00805467) | AstraZeneca | 2008-08-01 |
| Effects of Different Antirheumatic Treatments of Arthritis on Antibody Response Following Vaccination Using Prevenar® (NCT00828997) | Region Skane | 2008-08-01 |
| A Study of ARRY-371797 in Patients With Rheumatoid Arthritis (NCT00729209) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2008-07-01 |
| A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MTRX1011A in Patients With Rheumatoid Arthritis (NCT00718588) | Genentech, Inc. | 2008-07-01 |
| RESTART C0168Z05 Rheumatoid Arthritis Study (NCT00714493) | Centocor Ortho Biotech Services, L.L.C. | 2008-07-01 |
| Study of Controlled Release Formulations of CE-224,535 Against the Immediate Release Formulation in Normal Volunteers (NCT00782600) | Pfizer | 2008-07-01 |
| Safety, Tolerance, Pharmacokinetics and Activity of HE3286 in Patients With Rheumatoid Arthritis (NCT00712114) | Harbor Therapeutics | 2008-07-01 |
| Pre-operative Rehabilitation Exercise Program for Total Knee Arthroplasty (NCT00493142) | University of Alberta | 2008-07-01 |
| A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis (NCT00713544) | AstraZeneca | 2008-07-01 |
| Safety Study of a Single Dose of REGN88(SAR153191)in Patients With Rheumatoid Arthritis (NCT01055899) | Regeneron Pharmaceuticals | 2008-07-01 |
| Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (NCT00717236) | UCB Pharma | 2008-07-01 |
| Mass Balance and Metabolic Profiling of [14C]AZD5672 in Healthy Male Volunteers (NCT00711074) | AstraZeneca | 2008-06-01 |
| CAMEO: Canadian Methotrexate and Etanercept Outcome Study (NCT00654368) | Amgen | 2008-06-01 |